About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2013 (2013), Article ID 239241, 7 pages
http://dx.doi.org/10.1155/2013/239241
Clinical Study

Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer

1Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA
2Section of Biostatistics, Mayo Clinic Florida, Jacksonville, FL 32224, USA
3Department of Urology, Mayo Clinic Florida, Jacksonville, FL 32224, USA
4Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, MN 55905, USA

Received 21 February 2013; Accepted 12 March 2013

Academic Editors: J. Bentel, A. E. Bilsland, B. Comin-Anduix, A. E. Pinto, and L.-M. Sun

Copyright © 2013 Jennifer L. Peterson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Pound, A. W. Partin, M. A. Eisenberger, D. W. Chan, J. D. Pearson, and P. C. Walsh, “Natural history of progression after PSA elevation following radical prostatectomy,” Journal of the American Medical Association, vol. 281, no. 17, pp. 1591–1597, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Buskirk, T. M. Pisansky, S. E. Schild et al., “Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system,” Journal of Urology, vol. 176, no. 3, pp. 985–990, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Trock, M. Han, S. J. Freedland et al., “Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy,” Journal of the American Medical Association, vol. 299, no. 23, pp. 2760–2769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Stephenson, P. T. Scardino, M. W. Kattan et al., “Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy,” Journal of Clinical Oncology, vol. 25, no. 15, pp. 2035–2041, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Parker, M. G. Heckman, K. J. Wu et al., “Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 5, pp. 1364–1370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. S. Parker, M. G. Heckman, Y. Sheinin et al., “Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 79, no. 5, pp. 1343–1349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Heckman, A. S. Parker, K. J. Wu et al., “Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer,” Prostate, vol. 72, no. 16, pp. 1757–1766, 2012. View at Publisher · View at Google Scholar
  8. H. G. Skinner and G. G. Schwartz, “Serum calcium and incident and fatal prostate cancer in the national health and nutrition examination survey,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2302–2305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. G. Skinner and G. G. Schwartz, “A prospective study of total and ionized serum calcium and fatal prostate cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 2, pp. 575–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. L. Amling, E. J. Bergstralh, M. L. Blute, J. M. Slezak, and H. Zincke, “Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?” Journal of Urology, vol. 165, no. 4, pp. 1146–1151, 2001. View at Scopus
  11. J. R. Bernard Jr., S. J. Buskirk, M. G. Heckman et al., “Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, pp. 735–740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. K. Ritchie, K. G. Thomas, L. R. Andrews, D. J. Tindall, and L. A. Fitzpatrick, “Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis,” Prostate, vol. 30, pp. 183–187, 1997. View at Publisher · View at Google Scholar
  13. J. L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, and E. M. Brown, “Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells,” American Journal of Physiology—Endocrinology and Metabolism, vol. 281, no. 6, pp. E1267–E1274, 2001. View at Scopus
  14. J. Liao, A. Schneider, N. S. Datta, and L. K. McCauley, “Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis,” Cancer Research, vol. 66, no. 18, pp. 9065–9073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Huncharek, J. Muscat, and B. Kupelnick, “Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies,” Nutrition and Cancer, vol. 60, no. 4, pp. 421–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Gao, M. P. LaValley, and K. L. Tucker, “Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis,” Journal of the National Cancer Institute, vol. 97, no. 23, pp. 1768–1777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Halthur, A. L. V. Johansson, M. Almquist et al., “Serum calcium and the risk of prostate cancer,” Cancer Causes and Control, vol. 20, no. 7, pp. 1205–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. K. Tollefson, M. T. Gettman, M. L. Blute, E. J. Bergstralh, L. J. Rangel, and R. J. Karnes, “Serum calcium is not predictive of aggressive prostate cancer after radical prostatectomy,” Urology, vol. 77, no. 5, pp. 1161–1165, 2011. View at Publisher · View at Google Scholar · View at Scopus